We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
RARRES3
  • TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Dictionary

GENERAL INFORMATION

Gene name

RARRES3

Gene description

Retinoic acid receptor responder (tazarotene induced) 3

Protein class

Predicted intracellular proteins
Predicted membrane proteins

Predicted localization

Intracellular,Membrane

Number of transcripts

3
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Cell line enhanced (CAPAN-2, RPTEC TERT1, SK-BR-3)
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

ANTIBODY IHC RELIABILITY

Reliability score

Pending cancer tissue analysis.

PROGNOSTIC SUMMARY

Prognostic marker in pancreatic cancer (unfavourable), breast cancer (favourable) and cervical cancer (favourable).
Pancreatic cancer p<0.001
Breast cancer p<0.001
Cervical cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Pending cancer tissue analysis


STAINING SUMMARY

 

GENE INFORMATION

Gene name

RARRES3 (HGNC Symbol)

Synonyms

HRASLS4, TIG3

Description

Retinoic acid receptor responder (tazarotene induced) 3 (HGNC Symbol)

Entrez gene summary

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]

Chromosome

11

Cytoband

q12.3

Chromosome location (bp)

63536809 - 63546462

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000133321 (version 83.38)

Entrez gene

5920

UniProt

Q9UL19 (UniProt - Evidence at protein level)

neXtProt

NX_Q9UL19

Antibodypedia

RARRES3 antibodies

PROTEIN BROWSER

RARRES3-001
RARRES3-002
RARRES3-201

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

RARRES3-001
ENSP00000255688
ENST00000255688
Q9UL19 [Direct mapping]
Retinoic acid receptor responder protein 3
Show all
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   TMHMM predicted membrane proteins
   # TM segments-based
   1TM proteins predicted by MDM
Show all
GO:0004623 [phospholipase A2 activity]
GO:0005515 [protein binding]
GO:0006644 [phospholipid metabolic process]
GO:0008285 [negative regulation of cell proliferation]
GO:0016021 [integral component of membrane]
GO:0016042 [lipid catabolic process]
Show all
164 aa
18.2 kDa
No 1
RARRES3-002
ENSP00000402943
ENST00000439013
Q9UL19 [Direct mapping]
Retinoic acid receptor responder protein 3
Show all
Predicted intracellular proteins
Show all
GO:0004623 [phospholipase A2 activity]
GO:0005515 [protein binding]
GO:0006644 [phospholipid metabolic process]
GO:0008285 [negative regulation of cell proliferation]
GO:0016021 [integral component of membrane]
GO:0016042 [lipid catabolic process]
Show all
156 aa
17.4 kDa
No 0
RARRES3-201
ENSP00000346431
ENST00000354445
A6NG31 [Direct mapping]
Retinoic acid receptor responder protein 3
Show all
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   TMHMM predicted membrane proteins
   # TM segments-based
   1TM proteins predicted by MDM
Show all
GO:0016021 [integral component of membrane]
Show all
164 aa
18.2 kDa
No 1

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.